Micro Solutions Life ScienceRU

Micro Solutions / Life Science

HemeaccuTest DNA (108 genes) and RNA (53 genes)

CE-IVD panel for hematological tumors: 108 DNA genes and 53 RNA genes in one test

Product overview

CE-IVD panel for hematological tumors: 108 DNA genes and 53 RNA genes in one test

for acute leukemia, lymphoma, multiple myeloma and MDS/MPN

HEMEaccuTest combines a DNA panel of 108 genes and an RNA panel of 53 genes for comprehensive NGS diagnostics of hematological tumors with CE-IVD certification.

The kit includes two next-generation sequencing panels: a DNA panel of 108 genes significant in acute leukemia, lymphoma, multiple myeloma and myelodysplastic/myeloproliferative syndromes, and an RNA panel of 53 genes to detect fusion transcripts. The test detects single nucleotide substitutions at an allel frequency of 1-2% and Insertions / deletions - from 2-3%, the result is formed in 2-3 days.

The HEMEaccuTest DNA and RNA panels are CE-IVD certified, and the repeated tests confirm 100% sensitivity and specificity.

Key figures

108

DNA panels

53

sildenafil

CE-IVD

certification

2-3 days

time-frame

Applications

Models and configurations

Panel coverage

Analytical characteristics

Time limit for implementation

DNA panel

Genes108 (acute leukemia, lymphoma, multiple myeloma, MDS/MPN)

RNA panel

Genes53 (merged transcripts)

Analytical characteristics

SNV sensitivityfrom 1-2% allelic frequency
Sensitivity of INDELfrom 2-3% allelic frequency
Repeatability100% sensitivity and specificity

Term and certification

Time frame for analysis2-3 days
StatusCE-IVD

Related equipment types

Related products

Classification

Documents

Manufacturer sources